Loading clinical trials...
Loading clinical trials...
Erythropoietins in Management of Anemia of End Stage Renal Disease: A Prospective Study From Qatar.
Conditions
Interventions
Epoetin alpha or beta (Epoetin group)
Darbepoetin alfa
+1 more
Locations
1
Qatar
Fahd Bin Jassem Dialysis Centre
Doha, Qatar
Start Date
March 1, 2012
Primary Completion Date
April 1, 2013
Completion Date
June 1, 2013
Last Updated
September 13, 2017
Lead Sponsor
Hamad Medical Corporation
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions